NewAmsterdam Pharma Company NV (NAMS) Q4 2024 Earnings

Nov 6Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-1.06
-0.71
-0.35
0

Details

Expected EPS
-0.499222
Actual EPS
-0.18
Surprise EPS
0.32
Surprise Percent
+63.94%

Description

⁨NewAmsterdam Pharma Company NV⁩ (⁦NAMS⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts